Endocrine biomarkers related to sleep-wake cycle and sleep disturbances in patients with bipolar disorder: A systematic review

• Leticia González-Blanco ^[1] ; Carlota Moya-Lacasa ^[1] ; Sara Jiménez-Fernández ^[2] ; Clara Martínez-Cao ^[1] ; Mercedes Valtueña-García ^[1] ; Francesco Dal Santo ^[1] ; M. Paz García-Portilla ^[1] ; Luis Gutiérrez-Rojas ^[3]
  1. [1] Universidad de Oviedo

     Universidad de Oviedo

     Oviedo, España

     
  2. [2] Child and Adolescent Mental Health Unit, Jaén Medical Center, Jaén, Spain/ CTS-549 Research Group, Institute of Neurosciences, University of Granada, Granada, Spain
  3. [3] CTS-549 Research Group, Institute of Neurosciences, University of Granada, Granada, Spain / Psychiatry Service, San Cecilio University Hospital, Granada, Spain

  Mostrar afiliaciones +
• Localización: European journal of psychiatry, ISSN 0213-6163, Vol. 36, Nº 4, 2022, págs. 223-229
• Idioma: inglés
• Enlaces
  • Texto completo (pdf)
• Resumen

  • Background and objectives Sleep and circadian disturbances have been widely studied in patients with bipolar disorder. However, there is no clear evidence about the role of peripheral biomarkers of the circadian cycle in this population. This systematic review aims to identify potential endocrine blood biomarkers of circadian rhythms and study their relationship with sleep problems in these patients.

    Methods An electronic search was performed of PubMed and PsycINFO databases. It included articles about the topic from 1991 through 2021. The search strategy was: ("peripheral biomarkers" OR "biological markers" OR biomarker OR cortisol OR melatonin OR orexin OR hypocretin) AND (blood OR serum OR plasma) AND (“sleep-wake” OR "circadian rhythm" OR sleep OR insomnia) AND "bipolar." Results After excluding duplicates, 92 records were obtained. Only 5 studies met the inclusion criteria (n=499; bipolar disorder=125; unipolar depression=148; schizophrenia=80; controls=146). The endocrine parameters analyzed were: cortisol (3 studies), melatonin (1 study), and orexin-A (1 study). Overall, no significant associations were detected between these biomarkers and sleep disturbances, assessed with subjective (psychometric evaluation) and/or objective (polysomnography) measures.

    Conclusion This review highlights the lack of studies exploring the role of endocrine biomarkers related to circadian function in the pathophysiology of sleep disturbances in bipolar disorder.